Angiodynamics (ANGO) Revenue (2010 - 2026)

Angiodynamics has reported Revenue for 17 years, with the latest figure at $78.4 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 8.91% year-over-year to $78.4 million; the trailing twelve-month figure through Feb 2026 stood at $313.7 million (up 10.73% YoY), and the FY2025 full-year result was $292.5 million, down 3.76% from the prior year.
• Revenue for Q1 2026 stood at $78.4 million, down from $79.4 million in the prior quarter.
• The five-year high for Revenue was $91.1 million in Q2 2023, with the low at $67.5 million in Q3 2024.
• Historically, Revenue has averaged $78.2 million across 5 years, with a median of $78.7 million in 2023.
• Annual changes were most pronounced in 2022 — Revenue advanced 13.22% — and 2024, when it declined 22.06%.
• Angiodynamics' Revenue stood at $85.4 million in 2022, then declined by 7.44% to $79.1 million in 2023, then retreated by 7.88% to $72.8 million in 2024, then climbed by 9.04% to $79.4 million in 2025, then decreased by 1.27% to $78.4 million in 2026.
• The last three Revenue figures came in at $78.4 million (Q1 2026), $79.4 million (Q4 2025), and $75.7 million (Q3 2025), per Business Quant data.